BTK Inhibitor DTRMWXHS-12 in Mantle Cell Lymphoma

NCT03836768 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Mantle Cell Lymphoma

Interventions

DRUG: DTRMWXHS-12

Sponsor

Zhejiang DTRM Biopharma